Safety and Efficacy of [177Lu]-Psma-i&t Radioligand Therapy in Octogenarians with Metastatic Castration-Resistant Prostate Cancer: Report on 80 Patients over the Age of 80 Years.
JOURNAL OF NUCLEAR MEDICINE（2023）
关键词
metastatic castration-resistant prostate cancer,radioligand therapy,prostate-specific membrane antigen,[Lu-177]-PSMA,elderly patients
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要